Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Drug Manufacturing Facilities on Tap for Pharma Grade Marijuana Expansion

By HempTech Corp. | December 30, 2016

HempTech (HTCO) to build out drug development and manufacturing facility for Biotica Pharmaceuticals—HempTech’s automation technology helps grow pharma grade strains in 2017.

HempTech Corp., a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the cultivators of legal industrial hemp and marijuana, has agreed to buildout a drug development and manufacturing facility, one of many, for Biotica Pharmaceuticals beginning second quarter 2017.

The new drug development and manufacturing facility will contain grow, lab extraction and laboratory facilities. HempTech will use its most sophisticated grow system, the “grow.droid,” in conjunction with CognetiX for development and delivery of pharmaceutical grade strains for use of medical discovery by Biotica. HempTech is the only cannabis grow technology provider offering advanced CEA and sophisticated analytics for development of pharmaceutical grade marijuana strains for pharmaceuticals globally.

Biotica Pharmaceuticals has developed BPRx technology, which is a novel combinatorial library of phytocannabinoids and endocannabinoids for treating various human diseases. Biotica’s current technology includes;

  • BPRx-060216: Lead drug candidate to treat Eosinopilic Esophagitis (EoE)
  • BPRx-060234: Lead drug candidate to treat early stages of Alzheimer’s disease

Biotica, a privately held pharmaceutical company, has applied for two world-wide patent rights for the platform technologies and for specific novel drug formulations. They are actively procuring a portfolio of patents, trademarks, and trade secrets to reinforce and protect their technologies. They are conducting discovery research both in-house and with joint development agreements using their platform technology. www.bioticapharma.com.

HempTech supplies technology and automation systems to cannabis growers. www.hemptechcorp.com.

(Source: Marketwired)


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50